224 related articles for article (PubMed ID: 27011378)
1. Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.
Polonsky M; Rozanova J; Azbel L; Bachireddy C; Izenberg J; Kiriazova T; Dvoryak S; Altice FL
AIDS Behav; 2016 Dec; 20(12):2950-2960. PubMed ID: 27011378
[TBL] [Abstract][Full Text] [Related]
2. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
3. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
[TBL] [Abstract][Full Text] [Related]
5. Why People Who Inject Drugs Voluntarily Transition Off Methadone in Ukraine.
Rozanova J; Marcus R; Taxman FS; Bojko MJ; Madden L; Farnum SO; Mazhnaya A; Dvoriak S; Altice FL
Qual Health Res; 2017 Nov; 27(13):2057-2070. PubMed ID: 28942704
[TBL] [Abstract][Full Text] [Related]
6. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
[TBL] [Abstract][Full Text] [Related]
7. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
[TBL] [Abstract][Full Text] [Related]
8. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.
Bachireddy C; Bazazi AR; Kavasery R; Govindasamy S; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2011 Jul; 116(1-3):151-7. PubMed ID: 21232882
[TBL] [Abstract][Full Text] [Related]
9. Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.
Izenberg JM; Bachireddy C; Wickersham JA; Soule M; Kiriazova T; Dvoriak S; Altice FL
Int J Drug Policy; 2014 Sep; 25(5):845-52. PubMed ID: 24951025
[TBL] [Abstract][Full Text] [Related]
10. Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.
Bazazi AR; Wickersham JA; Wegman MP; Culbert GJ; Pillai V; Shrestha R; Al-Darraji H; Copenhaver MM; Kamarulzaman A; Altice FL
Contemp Clin Trials; 2017 Aug; 59():1-12. PubMed ID: 28479216
[TBL] [Abstract][Full Text] [Related]
11. Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
Morozova O; Dvoriak S; Pykalo I; Altice FL
Drug Alcohol Depend; 2017 Apr; 173():132-138. PubMed ID: 28242537
[TBL] [Abstract][Full Text] [Related]
12. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
[TBL] [Abstract][Full Text] [Related]
13. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
14. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
Huang YF; Kuo HS; Lew-Ting CY; Tian F; Yang CH; Tsai TI; Gange SJ; Nelson KE
Addiction; 2011 Aug; 106(8):1437-45. PubMed ID: 21438941
[TBL] [Abstract][Full Text] [Related]
15. Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China--a prospective study.
Chen W; Xia Y; Hong Y; Hall BJ; Ling L
Harm Reduct J; 2013 Oct; 10():23. PubMed ID: 24107380
[TBL] [Abstract][Full Text] [Related]
16. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.
Vijay A; Bazazi AR; Yee I; Kamarulzaman A; Altice FL
J Subst Abuse Treat; 2015 Jul; 54():29-36. PubMed ID: 25841703
[TBL] [Abstract][Full Text] [Related]
17. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
[TBL] [Abstract][Full Text] [Related]
18. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
[TBL] [Abstract][Full Text] [Related]
19. Implementing methadone maintenance treatment in prisons in Malaysia.
Wickersham JA; Marcus R; Kamarulzaman A; Zahari MM; Altice FL
Bull World Health Organ; 2013 Feb; 91(2):124-9. PubMed ID: 23554524
[TBL] [Abstract][Full Text] [Related]
20. Incarcerated intravenous heroin users: predictors of post-release utilization of methadone maintenance treatment.
Lin HC; Wang PW; Yang YH; Tsai JJ; Yen CF
J Addict Dis; 2016; 35(2):109-18. PubMed ID: 26670167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
